
Seytri S 1000mg/500mg Injection
Marketer
Hauz Pharma Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Seytri S 1000mg/500mg Injection
Combiflox, a dual-action injectable medication (1000mg/500mg), combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical practitioner. Complete the prescribed dosage; premature cessation may compromise effectiveness. Regular appointments are crucial. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) require urgent medical help. Inform your physician about all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration facilitate recovery. Follow-up laboratory tests may be conducted to assess treatment efficacy.
Uses of Seytri S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Seytri S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Seytri S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Seytri S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Seytri S 1000mg/500mg Injection works:
Seytri S injection, containing 1000mg Ceftriaxone and 500mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The inclusion of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Seytri S 1000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Seytri S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Seytri S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Seytri S 1000mg/500mg Injection can lead to reduced awareness, visual disturbances, drowsiness, and vertigo. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Seytri S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 1000mg/500mg Seytri S Injection requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Seytri S 1000mg/500mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Seytri S 1000mg/500mg Injection :
Omit a Seytri S 1000mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Seytri S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
